JPH0541626B2 - - Google Patents
Info
- Publication number
- JPH0541626B2 JPH0541626B2 JP88227086A JP22708688A JPH0541626B2 JP H0541626 B2 JPH0541626 B2 JP H0541626B2 JP 88227086 A JP88227086 A JP 88227086A JP 22708688 A JP22708688 A JP 22708688A JP H0541626 B2 JPH0541626 B2 JP H0541626B2
- Authority
- JP
- Japan
- Prior art keywords
- dopa
- group
- compound
- acid
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63227086A JPH02138A (ja) | 1987-09-18 | 1988-09-10 | Ｌ‐ドーパ誘導体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23429987 | 1987-09-18 | ||
| JP62-234299 | 1987-09-18 | ||
| JP3126088 | 1988-02-13 | ||
| JP63-31260 | 1988-02-13 | ||
| JP63227086A JPH02138A (ja) | 1987-09-18 | 1988-09-10 | Ｌ‐ドーパ誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02138A JPH02138A (ja) | 1990-01-05 |
| JPH0541626B2 true JPH0541626B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-06-24 |
Family
ID=26369718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63227086A Granted JPH02138A (ja) | 1987-09-18 | 1988-09-10 | Ｌ‐ドーパ誘導体 |
Country Status (12)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003070245A1 (en) * | 2002-02-15 | 2003-08-28 | Darpharma, Inc. | Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| WO2004052841A1 (en) * | 2002-12-06 | 2004-06-24 | Xenoport, Inc. | Carbidopa prodrugs and uses thereof |
| US6970629B2 (en) | 2002-12-19 | 2005-11-29 | Corning Cable Systems Llc | Optical tube assembly having a dry insert and methods of making the same |
| US7471862B2 (en) | 2002-12-19 | 2008-12-30 | Corning Cable Systems, Llc | Dry fiber optic cables and assemblies |
| US20090190890A1 (en) | 2002-12-19 | 2009-07-30 | Freeland Riley S | Fiber optic cable having a dry insert and methods of making the same |
| IL154318A (en) | 2003-02-06 | 2010-05-31 | Sarah Herzog Memorial Hospital | Pharmaceutical compositions for the treatment of movement disorders |
| KR101287297B1 (ko) | 2004-06-04 | 2013-07-23 | 제노포트 인코포레이티드 | 레보도파 프로드러그, 및 그의 조성물 및 용도 |
| US7323585B2 (en) * | 2004-06-04 | 2008-01-29 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
| AU2006322051B2 (en) * | 2005-12-05 | 2011-09-29 | Xenoport, Inc. | Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| CA2673336A1 (en) | 2006-12-21 | 2008-06-26 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| US7829592B2 (en) | 2006-12-21 | 2010-11-09 | Xenoport, Inc. | Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| US8399513B2 (en) | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
| CN102186804A (zh) | 2008-10-20 | 2011-09-14 | 克塞诺波特公司 | 合成左旋多巴酯前药的方法 |
| KR101025612B1 (ko) * | 2008-11-10 | 2011-03-30 | 한국해양연구원 | 신규 화합물인 Ｒａｍａｌｉｎ 및 그 용도 |
| JP2013520521A (ja) | 2009-11-09 | 2013-06-06 | ゼノポート，インコーポレーテッド | レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法 |
| ES2614179T3 (es) | 2010-03-04 | 2017-05-30 | Orion Corporation | Uso de levodopa, carbidopa y entacapona para el tratamiento de la enfermedad de Parkinson |
| CN103694127B (zh) * | 2013-12-30 | 2015-04-01 | 上海交通大学 | 链霉菌属菌种所产的化合物及该化合物的制备方法和应用 |
| SG11201703170RA (en) | 2014-10-21 | 2017-05-30 | Abbvie Inc | Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease |
| KR20180004756A (ko) | 2015-05-06 | 2018-01-12 | 신애질 코포레이션 | 약물 입자를 함유하는 제약 현탁액, 그의 투여를 위한 장치, 및 그의 사용 방법 |
| WO2019097120A1 (en) | 2017-11-16 | 2019-05-23 | Orion Corporation | New use and pharmaceutical dosage forms |
| BR112021009353A2 (pt) | 2018-11-15 | 2021-11-23 | Abbvie Inc | Formulações farmacêuticas para administração subcutânea |
| US20220213128A1 (en) * | 2021-01-03 | 2022-07-07 | RockGen Therapeutics LLC | L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease |
| US20240415800A1 (en) * | 2021-10-11 | 2024-12-19 | The Johns Hopkins University | Dopa and caffeic acid analogs as novel gcpii inhibitors |
| WO2025075499A1 (en) | 2023-10-02 | 2025-04-10 | Universiteit Van Amsterdam | Reducing dopamine feed-back inhibition in dopaminergic cells by tadalafil. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US393923A (en) * | 1888-12-04 | Samuel preston | ||
| US2868818A (en) * | 1953-12-15 | 1959-01-13 | Merck & Co Inc | Alpha methyl phenylalanines |
| US3725470A (en) * | 1969-05-14 | 1973-04-03 | Hoffmann La Roche | Amino acid derivatives |
| CH562199A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1970-10-30 | 1975-05-30 | Hoffmann La Roche | |
| BE793426A (fr) * | 1971-12-28 | 1973-06-28 | Lannacher Heilmittel G M B H | Derives de phenylalanine |
| US3983138A (en) * | 1973-09-25 | 1976-09-28 | Merck & Co., Inc. | Amino acid esters |
| US3891696A (en) * | 1973-11-02 | 1975-06-24 | Interx Research Corp | Novel, transient pro-drug forms of l-dopa |
| US3939253A (en) * | 1973-11-02 | 1976-02-17 | Interx Research Corporation | Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease |
| US4401676A (en) * | 1977-06-01 | 1983-08-30 | Merck & Co., Inc. | Novel α-amino acids |
| US4311706A (en) * | 1980-01-22 | 1982-01-19 | Interx Research Corporation | Novel dopa/dopamine prodrugs |
-
1988
- 1988-09-10 JP JP63227086A patent/JPH02138A/ja active Granted
- 1988-09-14 CA CA000577320A patent/CA1316180C/en not_active Expired - Fee Related
- 1988-09-15 IL IL87765A patent/IL87765A0/xx unknown
- 1988-09-16 EP EP88115183A patent/EP0309827B1/en not_active Expired - Lifetime
- 1988-09-16 PT PT88526A patent/PT88526B/pt not_active IP Right Cessation
- 1988-09-16 KR KR1019880012032A patent/KR890005031A/ko not_active Withdrawn
- 1988-09-16 DE DE8888115183T patent/DE3867403D1/de not_active Expired - Lifetime
- 1988-09-16 AU AU22340/88A patent/AU2234088A/en not_active Abandoned
- 1988-09-16 DK DK517588A patent/DK517588A/da not_active Application Discontinuation
- 1988-09-16 AT AT88115183T patent/ATE71083T1/de active
- 1988-09-16 US US07/245,348 patent/US4966915A/en not_active Expired - Fee Related
- 1988-09-17 CN CN88107165A patent/CN1032785A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL87765A0 (en) | 1989-02-28 |
| EP0309827A1 (en) | 1989-04-05 |
| DK517588A (da) | 1989-03-19 |
| CA1316180C (en) | 1993-04-13 |
| DE3867403D1 (de) | 1992-02-13 |
| DK517588D0 (da) | 1988-09-16 |
| EP0309827B1 (en) | 1992-01-02 |
| PT88526A (pt) | 1988-10-01 |
| JPH02138A (ja) | 1990-01-05 |
| KR890005031A (ko) | 1989-05-11 |
| US4966915A (en) | 1990-10-30 |
| ATE71083T1 (de) | 1992-01-15 |
| AU2234088A (en) | 1989-03-23 |
| PT88526B (pt) | 1992-11-30 |
| CN1032785A (zh) | 1989-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0541626B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US5442110A (en) | Hydroxamic acid derivative | |
| JP4405602B2 (ja) | ヒストン脱アセチル化酵素阻害剤 | |
| KR101118807B1 (ko) | Ｏ-치환 히드록시아릴 유도체 | |
| JP2021511290A (ja) | タンパク質分解のためのスルホンアミド誘導体 | |
| CN105764909B (zh) | 用于治疗泛酸激酶相关神经变性(pkan)的稳定泛酰巯基乙胺衍生物及用于合成这样的化合物的方法 | |
| JP2001513767A (ja) | メタロプロテアーゼ阻害剤としての逆ヒドロキサメート誘導体 | |
| CN106146337A (zh) | 用于治疗ape1介导的疾病的醌化合物 | |
| JP2000191616A (ja) | 新規ジペプチジルアルデヒド誘導体およびそれを含有する医薬 | |
| JP3457687B2 (ja) | 白内障治療用薬剤 | |
| EP3989967B1 (en) | Compounds, compositions, and methods for protein degradation | |
| US4897423A (en) | Dinitrobenzenesulfonamides | |
| JPH05178804A (ja) | ニトラトアルカンカルボン酸誘導体、該誘導体の製造方法及び該誘導体を含有する心臓及び循環系疾患を予防する医薬 | |
| JP4310191B2 (ja) | タキサン誘導体結晶およびその製造方法 | |
| JP2009191041A (ja) | ヒドロキシメチルケトン誘導体 | |
| US6071960A (en) | Polyol succinates and their pharmaceutical formulation | |
| JPH08231505A (ja) | インドール含有スルホンアミド誘導体 | |
| WO1998054131A1 (fr) | Nouveaux derives sulfonamides | |
| WO2006082820A1 (ja) | 性器ヘルペス治療剤 | |
| EP0925786A1 (en) | Remedies for ischemic diseases | |
| JP4549851B2 (ja) | 新規α−ケトアミド誘導体およびその用途 | |
| JPWO2003024950A1 (ja) | クマリン誘導体 | |
| EP4545075A1 (en) | Calpain inhibitor | |
| EA000166B1 (ru) | Биологически активные уреидо-производные, полезные при лечении рассеянного склероза | |
| JP3190717B2 (ja) | 新規な置換イタコン酸誘導体 |